# A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

> **NCT06619509** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 90 (actual)

## Conditions studied

- Solid Tumours

## Interventions

- **DRUG:** Brigimadlin

## Key facts

- **NCT ID:** NCT06619509
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2030-12-30
- **Final completion:** 2030-12-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06619509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06619509, "A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT06619509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*